ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

FDA News: Clinton Nominates Jane Henney For FDA Commissioner

June 26, 1998

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

Publisher, Law Firm Settle Suit Over Newsletter Photocopy

November 15, 1991

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979